DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy

Abstract

Del DDR alterations are recurrent genomic events in patients with advanced RCC and were mostly clonal in this cohort. Loss-of-function events in these genes may affect outcome with I/O therapy in metastatic RCC, and these hypothesis-generating results deserve further study.